Meal prep can be a game-changer for easy GLP-1 breakfasts
doi: 10.1517/14656566.8.15.2593 47 BrayGM
There is limited evidence suggesting it may modestly raise GLP-1 levels, though findings are inconsistent and based on small trials
Stopping your treatment could mean losing the progress you've made and having to restart from the beginning
One placebo-controlled trial, called ATTAIN-MAINTAIN, followed adults who had previously completed the SURMOUNT-5 obesity trial, a randomized controlled study evaluating whether tirzepatide, the active ingredient in Zepbound, led to greater body weight reduction versus semaglutide in adults with obesity
Dosing convenience: MariTide, from Amgen, uses once-monthly subcutaneous dosing rather than weekly injections